Hilltop Holdings’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,318
Closed -$816K 564
2022
Q3
$816K Sell
3,318
-15
-0.5% -$4.05K 0.11% 174
2022
Q2
$825K Buy
3,333
+235
+8% +$63.4K 0.11% 186
2022
Q1
$1.03M Sell
3,098
-11
-0.4% -$3.39K 0.12% 168
2021
Q4
$1.12M Buy
3,109
+325
+12% +$110K 0.12% 172
2021
Q3
$906K Buy
2,784
+366
+15% +$124K 0.1% 201
2021
Q2
$755K Buy
2,418
+307
+15% +$94.2K 0.09% 236
2021
Q1
$673K Hold
2,111
0.09% 223
2020
Q4
$684K Hold
2,111
0.1% 215
2020
Q3
$585K Buy
2,111
+340
+19% +$98K 0.1% 207
2020
Q2
$428K Hold
1,771
0.08% 241
2020
Q1
$257K Buy
+1,771
New +$294K 0.06% 278
2019
Q4
Sell
-1,765
Closed -$314K 445
2019
Q3
$314K Sell
1,765
-1,024
-37% -$221K 0.06% 287
2019
Q2
$726K Sell
2,789
-913
-25% -$242K 0.15% 139
2019
Q1
$1.06M Sell
3,702
-77
-2% -$25.6K 0.22% 105
2018
Q4
$1.23M Sell
3,779
-925
-20% -$321K 0.3% 81
2018
Q3
$2.12M Buy
4,704
+26
+0.6% +$10.2K 0.44% 63
2018
Q2
$1.91M Buy
4,678
+97
+2% +$35.1K 0.41% 61
2018
Q1
$1.33M Buy
+4,581
New +$1.16M 0.23% 108

Other funds holding ABMD

Hilltop Holdings's ABMD Position: Q4 2022 in Review

Hilltop Holdings sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,318 shares — an estimated $816K sold.

Hilltop Holdings first reported a position in ABMD in Q1 2018 and held it in 18 quarters. The position peaked at $2.12M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Hilltop Holdings reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Hilltop Holdings sold 3,318 Abiomed Inc shares in Q4 2022, an estimated $816K.
  • Hilltop Holdings first reported a position in Abiomed Inc in Q1 2018 and held it in 18 quarters.
  • Hilltop Holdings's Abiomed Inc position peaked at $2.12M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Hilltop Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.